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E-mail: sajjadahmadpour@yahoo.comSince December 2019 a number of cases of coronavirus dis-
ease 2019 (COVID-19) have been reported from Wuhan, and
in just 3 months, the virus spread fromWuhan to Iran [1]. The
Islamic Republic of Iran, especially the city of Qom, is one of
the highest-risk areas for COVID-19. It is well documented in
the literature that close contact between COVID-19– infected
and –uninfected people increases the mortality rate in a
population [2].
Previously we reported that after the outbreak of COVID-
19 in Iran, the number of patients referred to our GI clinic in
Shahid Beheshti Hospital increased unusually, by 20% [3].
Because the need for suitable therapeutic or diagnostic
methods for better evaluation of GI disorders is irrefutable,
what control programmes are required to reduce close contact
between GI physicians and the referred infected patients? This
matter became urgent when five GI physicians in our clinic
were infected with COVID-19, with various forms of lung
involvement. The persistence of unusual GI symptoms not only
increased the numbers of patients referred to our clinic but
also led us to consider diagnostic or therapeutic procedures
such as endoscopy, endosonography or endoscopic retrograde
cholangiopancreatography to be risky procedures.
Here, we address preventive strategies that may significantly
reduce close contact between patients and gastrointestinal (GI)
physicians for successful control of COVID-19 infection.
GI physicians must be aware that in the COVID-19
pandemic, human-to-human transmission is the main mode ofThis is an open access artiinfection via close contact or through air droplets. Personal
protective equipment such as surgical masks, gowns, face
shields, gloves and hand disinfectants must be used by physi-
cians when providing any medical care, especially endoscopy,
that requires little physical distance between patients with
COVID-19 and physicians [4]. However, because of the lengthy
time requirement needed as well as the strong possibility of
aspiration of oral and faecal material during endoscopy, we
limited this procedure to emergency patients only. In these
patients— for example those with cholangitis, cholangiosepsis
or active GI bleeding—we tried to perform procedures with
the patient completely sedated while preserving a minimum safe
distance. In the case of some procedures, including endoscopic
retrograde cholangiopancreatography, endosonography or
therapeutic endoscopy for patients with GI bleeding, it may be
better if patients are intubated in order to reduce gastro-
esophageal reflux. In addition, appropriate waste storage and
handwashing after ending procedures are the main ways to
prevent virus spread.
We reminded staff members in the GI clinic of important
information so that extremely safe environments could be
created and so that staff members could learn how to protect
themselves from this deadly virus. Further, all entrance doors
to the endoscopy and colonoscopy buildings were sterilized
after completing the medical care of individual patients. For
infected patients, we orally informed those with unusual GI
symptoms that did not require medication that it was un-
necessary to visit our GI clinic again except in an emergency.
To prevent long lines of people seeking care in front of the
clinic, we employed more GI physicians. In addition, we called
all patients ahead of time and asked them to arrive at the clinic
on time.
In addition to hiring more healthcare providers, we checked
their body temperatures every day to ensure a healthyNew Microbe and New Infect 2020; 35: 100676
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members, we prevented them from working in the clinic by
isolating them under negative pressure until a negative result of
a SARS-CoV-2 test was obtained.
Our main aim was to do our best to prevent transmission of
COVID-19 infection from infected patients to uninfected GI
physicians and staff members during the performance of high-
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